A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy
Latest Information Update: 18 Apr 2025
At a glance
- Drugs Perfluorohexyloctane (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
Most Recent Events
- 15 Apr 2025 Status changed from active, no longer recruiting to completed.
- 18 Nov 2024 Planned End Date changed from 1 Sep 2024 to 13 Jan 2025.
- 18 Nov 2024 Planned primary completion date changed from 1 Sep 2024 to 13 Jan 2025.